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One possible factor determining recovery of trace amount of protein biomarker candidates during proteome analyses could be
adsorption on urine tubes. This issue, however, has not been well addressed so far. Recently, a new technical device of surface
coating by poly(2-methacryloyloxyethyl phosphorylcholine (MPC)-co-n-butyl methacrylate (BMA)) (poly(MPC-co-BMA)) has
been developed mainly to prevent the adsorption of plasma proteins. We assessed whether conventionally used urine tubes adsorb
trace amount of urinary proteins and, if any, whether the surface coating by poly(MPC-co-BMA) can minimize the adsorption.
Proteinuric urine samples were kept in poly(MPC-co-BMA)-coated and noncoated urine tubes for 15 min and possibly adsorbed
proteins and/or peptides onto urine tubes were analyzed by SDS-PAGE, 2-DE, and the MALDI-TOF MS. It was found that a
number of proteins and/or peptides adsorb on the conventionally used urine tubes and that surface coating by poly(MPC-co-
BMA) can minimize the adsorption without any signiﬁcant eﬀects on routine urinalysis test results. Although it remains to be
clariﬁed to what extent the protein adsorption can modify the results of urinary proteome analyses, one has to consider this
possible adsorption of urinary proteins when searching for trace amounts of protein biomarkers in urine.
1.Introduction
Urine has now become one of the most attractive biological
ﬂuids in clinical proteomics [1, 2]. A number of urinary
proteomic studies have been conducted and have revealed
urinary biomarker candidates for renal systemic diseases
and malignancies of urinary tract [3–5]. Proteomic analysis
of urines can be applied to biomarker search in nonrenal
d i s e a s e sa sw e l l[ 6–8].
Although urinary proteome analyses have been con-
ducted by various gel-based and gel-free techniques [9],
comprehensive urinary proteome analysis is not an easy task
because the urine has very diluted protein concentration
with high levels of salts. Sample preparation, processing,
and storage for urinary proteomics have been reviewed [10–
13]. More recently, an optimized quantitative proteomic
strategy for urine biomarker discovery was described [14].
In any event, maximal protein recovery from urine is
essential for detecting trace quantities of proteins present in
urine for potential biomarker discovery. For this purpose,
protein loss during sample preparation should be avoided.
One possible factor responsible for loss of trace amounts
of urinary proteins could be adsorption to sample tubes,
but this issue has not been well addressed so far to our
knowledge.
Manyattemptshavebeenmadetopreventtheadsorption
of plasma proteins and to improve blood compatibility
by surface modiﬁcation [15, 16]. Ishihara and coworkers
reported onrapid developmentofhydrophilicity andprotein
adsorption resistance by polymer surfaces bearing poly(2-
methacryloyloxyethyl phosphorylcholine (MPC)-co-n-butyl
methacrylate) (poly(MPC-co-BMA)) [17, 18].2 International Journal of Proteomics
We took advantage of this coating method in the present
studyandassessedwhetherconventionallyusedtubesadsorb
trace amount of urinary proteins and, if any, whether the
surface coating by poly(MPC-co-BMA) can minimize the
adsorption.
2.MaterialsandMethods
2.1. Urine Collection Tubes and Coating Method. Poly(MPC-
co-BMA) was obtained from AI BIO-CHIPS CO., LTD
(Tokyo, Japan). A total of 6 diﬀerent types of conventional
urine collection tubes were used in this study. Tubes made
from polystyrene (PS) (Cat# 10200), polypropylene(PP)
Cat# 72200, polyethylene terephthalate(PET) (Cat# 23540),
and styrene-butadiene copolymers/methyl methacrylate-
styrene (SBC/MS) (Cat# 17300) were purchased from TOYO
KAGAKU KIZAI Co., LTD., Japan. Tubes made from
acrylonitrile-styrene (AS) copolymers (Cat# 479511373)
were from Nittobo Medical Co., LTD., Japan and those
made from styrene-butadiene copolymers (SBC) (Cat#
3324A000A-10) were from ASIAKIZAI Co., LTD., Japan. The
c o n v e n t i o n a lt u b e sm a d eb yA Sw e r ec o a t e db yp o l y ( M P C -
co-BMA) as described by Futamura et al. [18].
2.2. Samples. Urine samples obtained from outpatients in
Chiba University Hospital were used. An aliquot of the
samples was taken for routine urinalysis, and the rest
of the samples were centrifuged (700×g, 5min at room
temperature), and the supernatant was subjected to assess
protein adsorption on test tubes as described below. All these
procedures were carried out within 2 hours after collection
of the samples.
2.3. Urine Sample Preparation for Electrophoresis (SDS-
PAGE and 2-DE) and MALDI-TOF MS. One mL of two
diﬀerent levels of pooled proteinuric urines (equivalent to
15mg/dL and 50mg/dL, resp.) obtained from 10 patients
with renal disease were put into poly(MPC-co-BMA)-coated
and noncoated urine correction tubes and were kept at
room temperature for 15min. After aspiration of the urines,
the tubes were washed with 200μL of PBS three times.
After the third wash and PBS being aspirated, 100μLo f
PAGE sample buﬀer (electrophoresis) (50mM Tris-HCl, pH
6.8 containing 50mM dithiothreitol, 0.5% SDS, and 10%
glycerol) or 1% TCA aqueous solution (MALDI-TOF MS
analysis) was added and the tubes were vortexed for 30sec
to dissolve possibly adsorbed proteins.
2.4. Gel-Based Analysis. The solution which contained pro-
teins possibly adsorbed on the urine tubes was then analyzed
using SDS-PAGE (Perfect NT Gel W, 10–20% acrylamide,
20wells; DRC Co., Ltd., Tokyo, Japan) according to the
manufacturer’s protocol. The gel was stained with CBB
(PhastGel Blue R; GE Healthcare, Little Chalfont, UK).
The proteins separated by SDS-PAGE were identiﬁed by in-
gel tryptic digestion of the proteins followed by MS. In-
gel tryptic digestion was performed as described previously
[19]. Molar quantities of recovered peptide fragments were
estimatedfromthestainingintensityoftheSDS-PAGEbands
that were digested in-gel with trypsin. Digested peptides
roughly equivalent up to 1pmol of protein were injected
into a trap column: 0.3 × 5mm L-trap column (Chemicals
Evaluation and Research Institute, Saitama, Japan), and
an analytical column: 0.1 × 50mm Monolith column
(AMR, Tokyo, Japan), which was attached to a HPLC
system (Nanospace SI-2; Shiseido Fine Chemicals, Tokyo,
Japan). The ﬂow rate of a mobile phase was 1μL/min. The
solvent composition of the mobile phase was programmed
to change in 35min cycles with varying mixing ratios of
solvent A (2%v/v CH3CN and 0.1%v/v HCOOH) to solvent
B (90%v/v CH3CN and 0.1%v/v HCOOH): 5–50%B
20min,50–95%B1min,95%B3min,95–5%B1min,5%B
10min. Puriﬁed peptides were introduced from HPLC to
an LTQ-XL (Thermo Scientiﬁc, Calif, USA), an ion trap
mass spectrometer (ITMS), via an attached Pico Tip (New
Objective, Mass, USA). The MS and MS/MS peptide spectra
were measured in a data-dependent manner according to
the manufacturer’s operating speciﬁcations. The Mascot
search engine (Matrix science, London, UK) was used to
identify proteins from the mass and tandem mass spectra of
peptides. Peptide mass data were matched by searching the
Human International Protein Index database (IPI, July 2008,
72079 entries, European Bioinformatics Institute) using the
MASCOTengine.Theminimumcriterionoftheprobability-
based MASCOT/MOWSE score was set with 5% as the
signiﬁcant threshold level.
For 2-DE analysis, we used the method described by
Oh-Ishi et al. [20] and Kawashima et al. [21]. Brieﬂy, one
mL aliquots of urine samples kept at room temperature
for 15min in poly(MPC-co-BMA)-coated and noncoated
urine correction tube were concentrated up to 20-fold
b yB J PC o n c e n t r a t o r( P r o C h e m ,M A ,U S A )t o5 0 μLa n d
lyophilized. The lyophilizate was resuspended by 200μLo f
Immobiline reagent (7M urea, 2M thiourea, 4% CHAPS,
2% DTT, 2% Pharmalyte, broad range pH 3–10). Finally,
50μL of the 5-fold urine sample was applied to the IEF
agarose gel. The agarose gel was then transferred to the
Perfect NT Gels W (10–20% gradient of polyacrylamide gel;
DRC. Co. Ltd, Tokyo, Japan) and the second electrophoresis
was performed. Protein spots on 2-DE gels were stained
with CBB. The protein spots were detected, quantiﬁed,
and matched with the 2-DE gel view analysis software,
Progenesis SameSpots (Nonlinear Dynamics Ltd., UK). The
protein spots were excised from the gel and identiﬁed, as we
previously described [19].
2.5. MS-Based Analysis. One mL aliquots of urine sam-
ples (containing 50mg/mL protein) were kept at room
temperature for 15min in poly(MPC-co-BMA)-coated
and noncoated urine collection tube. Proteins possibly
adsorbed on the tubes were collected as described above
for the gel-based method and were analyzed by the
MALDI-TOF MS. To obtain quantitative data of the
possibly adsorbed proteins, we used stable isotope-labeled
5.9kDa ﬁbrinogen alpha C chain fragment (FIC 5.9) as
an internal standard as described by Sogawa et al. [22].
We obtained the stable isotope-labeled synthetic FIC 5.9International Journal of Proteomics 3
Table 1: Proteins adsorbed on poly(MPC-co-BMA)-uncoated urine tubes.
No. ID M.W.a Score Queries matched pIb
1 Tamm-Horsfall urinary glycoprotein 69,761Da 250 15 4.96
2 Albumin 69,321Da 353 32 5.67
3 Semenogelin-1 52,131Da 114 6 9.26
4 Alpha-1-antichymotrypsin 47,651Da 281 11 5.32
5 Alpha-1-antitrypsin 46,737Da 85 3 5.37
6 Apolipoprotein A1 27,891Da 82 4 5.27
7 IGKV1-5 protein 25,765Da 313 7 5.74–6.30
8 Prostaglandin-H2 D-isomerase 21,029Da 98 5 8.37
9 Apolipoprotein C3 10,846Da 93 3 4.72
10 Protein S100-A8 10,835Da 86 3 6.51
11 SH3 domain-binding glutamic acid-rich-like protein 3 10,438Da 80 2 4.82
a,bTheoretical Mr and pI, as resulted from Compute pI/Mw tool of Expasy (http://us.expasy.org/tools/pi tool.html), are also indicated.
from the AnyGen Co., Ltd. (Kwangju, Korea). The amino
acid sequence of the peptide was SSSYSKQFTSSTSYNRG
DSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPV.
(The underlined amino acids were synthesized with 13C, 15N
uniformly labeled FMOC amino acids.). In urine analysis,
ten microliters of SID (stable isotope-labeled) -FIC 5.9
solution (0.5pmol/μL SID-FIC 5.9, MB-WCX binding
solution) and 5μL of urine sample were transferred to a
200μL PCR tube (Thermo Fisher Scientiﬁc K.K., Kanagawa,
Japan). In analysis of urine samples kept in tube, ten
microliters of SID-FIC 5.9 solution (0.025pmol/μL SID-FIC
5.9, MB-WCX binding solution) and 5μLo fe x t r a c t e d
samples (urine samples kept in tube) were transferred to a
200μLP C Rt u b e .A1 0 μL homogenous magnetic particle
solution was added, mixed with the other solutions, and
allowed to sit for 5min. The PCR tubes were placed in a
magnetic bead separator (MBS; Bruker Daltonics GmbH)
for 30s for magnetic ﬁxation of the MB-WCX particles. The
supernatant was aspirated, and the tubes were removed from
the MBS device. We added 100μL of the washing solution
and carefully mixed it with the magnetic beads. We then
replaced the tube into the MBS device and moved it back
and forth between adjacent wells on each side of the device’s
magnetic bar. After ﬁxation of the magnetic beads for 30s,
the supernatant was aspirated. We repeated this washing
procedure three times. After the ﬁnal wash, we eluted the
bound molecules by incubating them for 1min with 5μL
MB-WCX elution solution and then used the MBS device
to collect the eluate. For the ﬁnal step, we added 5μL of the
MB-WCX stabilization solution to the eluate. We then mixed
1μL of the eluate with 5μL of a matrix solution (0.3g/L
a-cyano-4-hydroxycinnamic acid in ethanol:acetone, 2:1).
We spotted 1 μL of the mixture onto an AnchorChip target
plate (Bruker Daltonics GmbH) and allowed it to dry.
Protein Calibration standard (Protein Calibration standard
1, Bruker Daltonics GmbH) was dissolved in 1251μL. We
applied 0.51μL of the solution to target spots in proximity
to the urine samples for external calibration.
We placed the AnchorChip target plate into the AutoFlex
II TOF/TOF mass spectrometer (Bruker Daltonics GmbH)
and into the UltraFlex III TOF/TOF mass spectrometer
(Bruker Daltonics GmbH), which is controlled by Flexcon-
trol software 3.0 (Bruker Daltonics GmbH). The instrument
was externally calibrated by standard procedures. The auto-
mated acquisition method included in the instrument soft-
ware generated all acquisitions. The automated acquisition
laser power was set between 25% and 35%. Spectra were
acquired in a positive linear mode in the mass range of 600
to 10,000Da.
We used FlexAnalysis software 3.0 to perform baseline
correctionandsmoothing.Theconcentrationoftheproteins
adsorbed to urine collection tube was estimated from the
ratio of the peak intensity of adsorbed proteins to the
peak intensity of SID-FIC 5.9. For identiﬁcation of peptides
as we previously described [23], the AnchorChip target
plate was also placed in an UltraﬂeXtreme TOF/TOF mass
spectrometer (Bruker Daltonics) and the MALDI-TOF/TOF
MS/MS spectrum was recorded in LIFT mode. Five hundred
laser shots from a total of 3000 laser shots were summed.
The MALDI-TOF/TOF MS/MS spectrum was subjected to
a database search using the Mascot (Matrix Science, London,
UK) database search engine. The search parameters were as
follows: no enzyme speciﬁcity, 25ppm mass tolerance for the
parent mass, and 0.2Da for fragment masses. No ﬁxed or
variable modiﬁcations were selected. The NCBInr database
was used for the search.
2.6. Urinalysis Testing
2.6.1. Quantitative Study. One hundred urine samples
requested for urinalysis on routine basis at the Division of
LaboratoryMedicineandClinicalGenetics,ChibaUniversity
Hospital were used. The urine samples were aliquoted
(10mL) to poly(MPC-co-BMA)-coated and noncoated col-
l e c t i o nt u b e sa n dw e r ek e p ta tr o o mt e m p e r a t u r ef o r
15min before use. Nine diﬀerent quantitative urinalysis
such as protein, glucose, creatinine, microalbumin, beta-
2-microglobulin, amylase, N-acetyl-β-D-glucosaminidase,
urea nitrogen, uric acid, and six kinds of electrolytes
were conducted using BioMajesty JCA-BM6010 (JEOL Ltd.,
Tokyo, Japan).4 International Journal of Proteomics
Table 2: Proteins which were reduced when kept in poly(MPC-co-BMA) noncoated urine tubes.
No. ID M.W.a Score Queries matched pIb
1 Ceruloplasmin 122,128Da 812 52 5.41
2 Lysosomal alpha-glucosidase 105,271Da 152 8 5.41
3 Alpha-N-acetylglucosaminidase 82,115Da 163 6 6.21
4 Serotransferrin 77,000Da 1500 95 6.70
5 Alpha-1-antitrypsin 46,707Da 253 12 5.37
6 Cell adhesion molecule 4 42,759Da 134 6 5.59
7 Prostate-speciﬁc antigen 28,723Da 80 2 7.26
8 IGK protein 26,218Da 1416 4 5.74–6.30
9 IGL protein 24,777Da 430 31 5.74–6.30
10 Alpha-1-acid glycoprotein 1 23,497Da 239 7 5.00
11 Prostaglandin 2D synthase 22,932Da 596 31 7.66
12 Prostaglandin-H2 D-isomerase 21,029Da 861 42 7.66
13 Transthyretin 15,877Da 856 37 5.35
14 Rheumatoid factor D5 light chain 12,758Da 273 6 5.74–6.30
15 Rheumatoid factor D6 light chain 12,520Da 273 6 5.74–6.30
a,bTheoretical Mr and pI, as resulted from Compute pI/Mw tool of Expasy (http://us.expasy.org/tools/pi tool.html), are also indicated.
2.6.2. Dipstick Urinalysis. The Uriﬂet S-9UB (Arkray Inc.,
Tokyo, Japan) and AUTION MAX AX-4030 (Arkray Inc.,
Tokyo, Japan) analyzers were used. Ten diﬀerent parameters
are assessed: speciﬁc gravity (SG, measured via a built-in
refractometer), erythrocytes, leukocytes, nitrite, pH, protein,
glucose, ketones, bilirubin, and urobilinogen.
2.6.3.UrinarySediments. TheAUTIONIQIQ-5210analyzer
(Arkray Inc., Tokyo, Japan) was used to determine urinary
sediments. This equipment includes digital imaging and
Auto-Particle Recognition (APR) (Chatsworth, CA, USA)
software to classify urine particles and quantitatively report
results. In this study, 4 categories red blood cells (RBC),
white blood cells (WBC), squamous epithelial cells (SEC),
and casts were classiﬁed by the APR software.
2.7. Statistical Analysis. The numerical data are presented
as the mean ± standard deviation (SD). We evaluated the
statistical signiﬁcance using IBM SPSS Statistics 18 software
(SPSS Inc., IL, USA). A P < 0.05 was considered signiﬁcant
using the Mann-Whitney U test.
3. Results
3.1. Detection of Urinary Proteins Adsorbed on Urine Tubes by
SDS-PAGE. Proteins adsorbed on the poly(MPC-co-BMA)-
coated and noncoated tubes were analyzed by SDS-PAGE. As
shown in Figure 1(a), a few distinct protein bands (60kDa,
66kDa and 100kDa) were noted in samples obtained from
noncoated AS tubes. No clear bands were visible in samples
obtained from poly(MPC-co-BMA)-coated AS tubes under
these experimental conditions. LC-MS analysis of trypsin
digests of these bands identiﬁed 11 proteins as listed in
Table 1. Protein adsorption on the tubes was observed in 6
diﬀerent types of conventionally used urine collection tubes
as shown in Figure 1(b).
3.2. 2-DE Analysis of Urine Samples Kept in Poly(MPC-
co-BMA)-Coated and Noncoated Tubes. Urine specimens
kept in poly(MPC-co-BMA)-coated and noncoated tubes
were subjected to the agarose 2-DE as described in the
Methods section. The representative patterns were presented
in Figure 1(c). Nine protein spots the intensities of which
were signiﬁcantly greater (P < 0.05) in samples kept at
poly(MPC-co-BMA)-coated tubes compared with those kept
at noncoated tubes were selected based on the results
obtained in seven diﬀerent experiments.
These diﬀerences were most likely as the results of more
protein adsorption on noncoated tubes. These spots were
excised and subjected to in-gel trypsin digestion followed
by LC-MS. A total of 15 proteins were identiﬁed as listed in
Table 2.
3.3. MALDI-TOF MS Analysis of Urinary Proteins Adsorbed
on Poly(MPC-co-BMA)-Coated and Noncoated Tubes.
Proteins and/or peptides adsorbed on the conventional
urine tubes were also detectable by the MALDI-TOF MS.
Figure 2(a) shows a representative spectrum of the adsorbed
proteins and peptides. The intensities of the two peaks
(2556m/z and 2654m/z) were notably greater in samples
obtained from poly(MPC-co-BMA) noncoated tubes.
Similar results were obtained in 7 diﬀerent experiments; the
expression levels of the two peaks expressed as the ratio to
the internal standard, SID-FIC 5.9, were signiﬁcantly greater
(P < 0.001) in poly(MPC-co-BMA) noncoated tubes than in
coated tubes. Using MALDI-TOF/TOF MS/MS technology,
we successfully identiﬁed the two peaks (2556m/z and
2654m/z) as internal sequences of the ﬁbrinogen alpha C
chain fragment. The peptide sequences of the 2556m/z and
2654m/z were DEAGSEADHEGTHSTKRGHAKSRP and
DEAGSEADHEGTHSTKRGHAKSRPV, respectively. The
mean value of the ratio of m/z 2654 to SID-FIC5.9 was 5.70
(Figure 2(a) Right panel) in poly(MPC-co-BMA) noncoatedInternational Journal of Proteomics 5
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Figure 1: (a) SDS-PAGE of adsorbed proteins to poly(MPC-co-BMA)-coated and noncoated urine tubes in two diﬀerent grades of
proteinuric samples. A few distinct protein bands are noted in samples obtained from noncoated tubes. Similar results were obtained in
9d i ﬀerent experiments. (b) SDS-PAGE of adsorbed proteins to 6 diﬀerent types of poly(MPC-co-BMA) noncoated conventionally used
urine collection tubes. AS: poly(acrylonitrile-styrene), PET: polyethylene terephthalate, PS: polystyrene, PP: polypropylene, SBC: styrene-
butadiene, and SBC/MS: styrene-butadiene copolymers/methyl methacrylate-styrene. (c) 2-DE of urinary proteins obtained from samples
kept at poly(MPC-co-BMA)-coated and noncoated urine tubes. Nine protein spots the intensities of which were signiﬁcantly greater (P <
0.05) in samples kept at poly(MPC-co-BMA)-coated tubes compared with those kept at noncoated tubes were selected based on the results
obtained in seven diﬀerent experiments. The 2-DE gels are shown for pH 3–10.6 International Journal of Proteomics
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Figure 2: Representative spectra of the MALDI-TOF MS of urinary proteins and/or peptides adsorbed on urinary tubes with and without
poly(MPC-co-BMA)coating (a)and thoseofurinesamples keptinthecoated and noncoated tubes (b).(a) Left:itwas notable that2556m/z
and 2645m/z peaks were observed in proteinuric samples only when obtained from the poly(MPC-co-BMA) non-coated tubes (the upper
panel). Similar results were obtained in 7 diﬀerent experiments. Right: the two peaks detectable in noncoated tubes were signiﬁcantly
attenuated in poly(MPC-co-BMA)-coated tubes (P < 0.001). (b) When urinary samples were kept in the coated and uncoated urine tubes,
relative peak intensities of the 2556m/z and 2645m/z peaks were attenuated in poly(MPC-co-BMA)-coated tubes (the upper panel), which
was conﬁrmed by the quantitative study using the internal standard (2556m/z; P < 0.007, 2653m/z; P < 0.014).
urine collection tube. It is 0.85μg/mL when converting it
into the protein concentration.
3.4. MALDI-TOF MS Analysis of Urine Samples Kept
in Poly(MPC-co-BMA)-Coated and Noncoated Tubes.
Figure 2(b) shows representative view of the spectrum of
urine samples kept in urine tubes. The relative intensities
of the two peaks (2556m/z and 2654m/z) were greater in
the samples kept in poly(MPC-co-BMA)-coated tubes than
those kept in noncoated tubes. Similar results were obtained
in 7 other experiments; the diﬀerences quantiﬁed using
the SID-FIC 5.9 were statistically signiﬁcant (P < 0.007 for
2556m/z and P < 0.014 for 2653m/z).
3.5. Routine Urinalysis. The quantitative values of urinalysis
parameters in samples kept in poly(MPC-co-BMA)-coated
and noncoated collection tubes are presented in Table 3.
They were all comparable between the two groups in linear
regression equation, slope of linearity, correlation coeﬃ-
cients ranged from 0.997 to 1.014. The results of dipstick
urinalysis and urinary sediment determinations were also
comparable between the two groups.
4. Discussion
The issue of preanalytical factors aﬀecting sample integrity
is often overlooked and yet is critically important. Although
preanalytical factors for serum or plasma proteome analysis
have been extensively studied, the impact of adsorption of
proteins and peptides on urine tubes on biomarker discovery
using urinary proteomics is not well investigated.
Theresultsofthisstudyindicatethatconventionallyused
urine collection tubes adsorb proteins and/or peptides andInternational Journal of Proteomics 7
Table 3: Quantitative values for urinalysis parameters in samples
kept in poly(MPC-co-BMA)-coated and noncoated urine collection
tubes.
Parameters Noncoated tube Coated tube
pH 6.17 ± 0.58 6.17 ± 0.58
Protein (mg/dL) 57.8 ± 136.5 58.5 ± 138.2
Glucose (mg/dL) 182.4 ± 556.3 184.2 ± 561.0
Creatinine (mg/mL) 1.2 ± 0.7 1.2 ± 0.7
Microalbumin (mg/L) 212.0 ± 323.4 212.4 ± 324.2
Beta-2-microglobulin (μg/L) 1771.3 ± 3269.7 1772.4 ± 3275.0
Amylase (IU/L) 298.2 ± 245.2 300.3 ± 246.5
N-acetyl-β-D-
glucosaminidase
(U/L)
17.4 ± 19.2 17.4 ± 19.2
Urea nitrogen (mg/dL) 620.2 ± 315.9 623.3 ± 317.8
Uric acid (mg/dL) 49.8 ± 27.5 50.0 ± 27.7
Calcium (mg/dL) 10.7 ± 9.7 10.8 ± 9.7
Magnesium (mg/dL) 6.8 ± 3.8 6.8 ± 3.8
Sodium (mEq/L) 106.9 ± 48.9 107.1 ± 49.1
Potassium (mEq/L) 45.4 ± 26.3 45.5 ± 26.4
Chlorine (mEq/L) 169.5 ± 85.4 169.7 ± 85.2
Inorganic phosphorus
(mg/dL) 53.1 ± 30.3 53.4 ± 30.6
that the surface coating of the tubes by poly(MPC-co-BMA)
can minimize the adsorption without any signiﬁcant eﬀects
on routine chemical determinations.
In this study, urine samples were kept in poly(MPC-
co-BMA)-coated and noncoated tubes for 15min. This is
because it is generally known that proteins adsorb onto a
surface within a few minutes when the material contacts
body ﬂuids such as blood, plasma, and tears [24–26].
Protein adsorption is one of the most important phe-
nomena in determination of the biocompatibility of mate-
rials [16, 18]. Several methods have been proposed to reduce
protein adsorption on medical devices.
Polymers composed of MPC and hydrophobic alkyl-
methacrylate units have been extensively used in many
medical devices as coating materials to improve the blood
compatibility of these devices [15–18]. However, this coating
requires a long wetting pretreatment time to achieve equi-
librium hydration by the reorientation of the phosphoryl-
choline groups [16, 27]. In this study, urinary proteins were
found to be adsorbed on poly(MPC-co-BMA) noncoated
urine collection tubes made from six diﬀerent types of
materials. Recently, Futamura et al. [18] succeeded in rapid
development of hydrophilicity and protein adsorption resis-
tance poly(ethylene terephthalate) (PET) surfaces bearing
poly(MPC-co-2-vinylnaphthalene(vN)) (PMvN). It should
be considered, however, that coating eﬀects on the plastic
tubes appear to be dependent on the initial properties of
the plastic tubes. We took advantage of this coating method
and showed that protein adsorption can be reduced in urine
samples as well.
Most of the proteins listed in Table 1 are representative
protein in urine and have theoretical isoelectric points
between 4.7 and 7.0, suggesting that proteins with isoelectric
point of this range are likely to be adsorbed on the
conventional urine tubes employed in this study. Since the
pH of the urine samples kept in poly(MPC-co-BMA)-coated
and noncoated tube was similar, it is unlikely that the
diﬀerences obtained in this study were due to pH diﬀerence.
It has been reported that the factor responsible for protein
adsorption to the plastic tube might depend on the relation
of sample pH and protein pI [28].
Three proteins (alpha-1-antitrypsin, IGKV1-5 protein,
prostaglandin-H2 D-isomerase) were detected in common
for two diﬀerent comparisons.
Ceruloplasmin, one of the proteins listed in Table 1,i sa
biomarker of uranium nephrotoxicity [29].
The use of the coated tubes did not have any impact
on the urine analysis of routine parameters. Since there
were no signiﬁcant diﬀerences in the quantitative data of
abundant urinary proteins including albumin and beta-2-
microglobulin, the eﬀects of adsorption on abundant pro-
teins may be minimal. But, in searching for urinary protein
biomarkers with low concentration, possible adsorption on
conventional urine tubes should be considered. Since the
material used in the conventional and noncoated tubes
employed in the present study is widely used around the
world, possible adsorption of trance amount of proteins to
urine collection tubes should be considered in proteome
analyses of urine samples.
5. Summary
Urine is one of the attractive bioﬂuids in clinical proteomics.
In chasing very low abundance urinary proteins and pep-
tides, however, loss of biomarker candidates by adsorption
on urine tubes should be considered. In this study, we found
that protein adsorption on the conventionally used urine
collection tubes is not negligible, and that the adsorption can
be reduced by using a tube coated by hydrophilic polymers
without any eﬀects on routine urinalysis.
I believe that these ﬁndings should be shared by those
who are interested in urinary proteomic study.
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